ObsEva to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Rhea-AI Summary

ObsEva SA (NASDAQ: OBSV; SIX: OBSN) announced a corporate update and investor meetings at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021. The presentation will be accessible on-demand from 7:00 a.m. ET on September 13, via the conference portal. ObsEva focuses on developing therapies for women’s reproductive health, with a late-stage clinical pipeline addressing issues like endometriosis and preterm labor.

News Market Reaction – OBSV

-2.22%

-2.22% Session move

In the trading session that priced this news, OBSV declined 2.22%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GENEVA, Switzerland September 7, 2021 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that Company Management will provide a corporate update and participate in one-on-one investor meetings at the H.C. Wainwright 23^rd Annual Global Investment Conference to be held September 13-15, 2021.

The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7:00 a.m. ET on Monday, September 13, 2021.

The presentation and archived webcast will also be accessible under "Events Calendar" in the investors section of ObsEva's website.

 

About ObsEva
ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids and preterm labor. ObsEva is listed on the NASDAQ Global Select Market and is trading under the ticker symbol “OBSV” and on the SIX Swiss Exchange where it is trading under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com.

 

For further information, please contact:

CEO Office contact
Shauna Dillon
Shauna.dillon@obseva.ch
+41 22 552 1550

Investor Contact
Joyce Allaire
jallaire@lifesciadvisors.com
+1 (617) 435-6602

 

Attachment

• Press Release in Pdf

FAQ

What is ObsEva's participation in the H.C. Wainwright Conference 2021?

ObsEva will provide a corporate update and engage in one-on-one investor meetings at the H.C. Wainwright Conference from September 13-15, 2021.

When can I access ObsEva's presentation during the conference?

The presentation will be available on-demand starting at 7:00 a.m. ET on September 13, 2021.

What is ObsEva's focus in women's health?

ObsEva develops therapies aimed at improving women's reproductive health, focusing on conditions such as endometriosis and uterine fibroids.

What is the ticker symbol for ObsEva?

ObsEva trades under the ticker symbol 'OBSV' on NASDAQ and 'OBSN' on the SIX Swiss Exchange.